Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. KONTAKT
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/KONTAKT
KONTAKT/
Blog
Key Takeaways from the 18th Annual Diabetes Technology Meeting (DTM)
Michael Lee, Senior Consultant, IVD Solutions
Jan 25, 2019
  • Blogs
  • Key Takeaways from the 18th Annual Diabetes Technology Meeting (DTM)

Advancements on the accuracy of BGM devices

This year’s focus concerned BGM accuracy in the point-of-care settings compared to home usage. Accuracy in this sense meant devices meeting regulatory standards (e.g., CLIA waived Nova Biomedical StatStrip), but also related to pre-analytical factors that can impact the accuracy of BGM. We heard from, Dr. Leslie Landree, team leader for the FDA’s Diabetes Diagnostics Devices Branch. She noted that the YSI 2900, currently not approved by the FDA, will soon phase out YSI 2300, signifying real change in diabetes treatment.

Harnessing technology to develop smarter CGMs

We also learned that Abbott provided insights on improving the MARD (Mean Absolute Relative Difference) of the 14-day FreeStyle Libre compared to the 10-day version through enhancing factory calibration methods. While, Medtronic presented updates on the development of a potential self-calibrating sensor leveraging Electrochemical Impedance Spectroscopy (EIS) technology.

In addition to well established manufacturers, several emerging developers presented updates on their progress. Waveform showed an internal study demonstrating that its Cascade CGM system, which is scheduled for commercialization in 2019, performed relatively on par with available CGM products.

Biorasis continued the development of its Glucowizzard implantable CGM (measuring 0.75 x 6 mm) that transmits glucose data to a smart watch. Notably, Lifecare showcased how it is leveraging 3D printing technology to develop a CGM device, enabling faster iterations of its designs during the development process. Posters presented by PercuSense, Eyesense, and a research group from the University of North Carolina (led by Dr. Koji Sode) on CGM development, underscore the growing focus in this category.

It was also encouraging to see that Convatec is developing a single on-body product with both a CGM probe and a redesigned insulin cannula, showing that advancements are being made in this area. Pacific Diabetes Technology is also working on a single CGM sensor and insulin infusion product. CapBio presented details on developing a cannula that limits tissue inflammation, enabling greater insulin absorption and potential for greater wear time. Taken together, these technology advances underscore the growing demand for safer and more comfortable on-body devices.

Pushing the development of AID systems

An area that generated strong interest focused on the progress of interoperable devices, leading to advancements in the development of AID systems. Panel sessions led by members of the FDA highlighted the need for establishing quality standards (e.g., iCGM criteria and digital health pre-certification) to ensure the safety of diabetes patients, while simultaneously accelerating the regulatory pathway for AID systems.

While AID systems have certainly improved diabetes management, inherent challenges such as multiple on-body products (separate CGM sensor and insulin infusion set), cannula occlusions, and skin irritations are still key developmental hurdles to overcome.

This event showed that there is growing evidence that wearable AID devices will play a larger role in diabetes management, while accuracy of sensor-based devices is improving.

Looking ahead

While this year’s DTM highlighted the varying developments in the field, we look forward to seeing even more progress at the Advanced Technologies and Treatment for Diabetes (ATTD) conference in Berlin, Germany in February 2019, and we hope to see you there.

Related solutions

Diabetes

Understand the science in treating diabetes with broadening populations, expanding treatment options, and new digital support tools.

Therapeutic & Specialty Expertise

Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.

Contact Us